Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Christine B. Mackay"'
Publikováno v:
Contemporary Clinical Trials Communications, Vol 2, Iss C, Pp 69-74 (2016)
Background: Participation in cancer clinical trials has been shown to increase overall survival with minimal increase in cost, but enrollment in adult cancer clinical trials remains low. One factor limiting enrollment is lack of insurance coverage, b
Externí odkaz:
https://doaj.org/article/9016f4f715b644c1bc978786be6da977
Autor:
Kaitlyn R. Antonelli, Suanna S. Bruinooge, Shellie D. Ellis, Jarron M. Saint Onge, Christine B. Mackay
Publikováno v:
Cancer. 123:2893-2900
BACKGROUND The Affordable Care Act (ACA) includes a mandate requiring most private health insurers to cover routine patient care costs for cancer clinical trial participation; however, the impact of this provision on cancer centers’ efforts to accr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::beac8438698d524b9d46722a8789604e
https://doi.org/10.1002/cncr.30689
https://doi.org/10.1002/cncr.30689
Autor:
Shellie D. Ellis, Ariel Shifter, Jessie Gills, Kelly L. Stratton, Brantley Thrasher, Mugur V. Geana, Andrew Zganjar, Charles McWilliams, Tomas L. Griebling, Christine B. Mackay
Publikováno v:
Trials
Trials, Vol 20, Iss 1, Pp 1-13 (2019)
Trials, Vol 20, Iss 1, Pp 1-13 (2019)
BackgroundFew community urologists offer cancer patients the opportunity to participate in cancer clinical trials, despite national guidelines that recommend it, depriving an estimated 260,000 urological cancer patients of guideline-concordant care e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04f7f9c753f43eea6abb46eb9af26105
http://europepmc.org/articles/PMC6781342
http://europepmc.org/articles/PMC6781342
Autor:
Christine B. Mackay, Mugur V. Geana, Jessie Gills, Andrew Zganjar, Deborah J. Moon, Tomas L. Griebling, Gayle Brekke, Shellie D. Ellis, J. Brantley Thrasher
Publikováno v:
Urol Oncol
Objective Engaging community urologists in referring patients to clinical trials could increase the reach of cancer trials and, ultimately, alleviate cancer disparities. We sought to identify determinants of referring patients to clinical trials amon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::16ab0f3de729b43412a31b0494167442
https://europepmc.org/articles/PMC6661185/
https://europepmc.org/articles/PMC6661185/
Autor:
Maurie Markman, Holly J. Smith, Gary Johnson, Gere S. diZerega, D.S. McMeekin, Scott Weir, Michael Baltezor, Katherine F. Roby, Jo Wick, Christine B. Mackay, Holly Maulhardt, Kathleen M. Moore, Gregory A. Reed, Stephen K. Williamson, Thomas K. Schulz, Jahna C. Espinosa, Charles J. Decedue
Publikováno v:
Cancer Chemotherapy and Pharmacology. 75:1075-1087
This multicenter, open-label, dose-escalating, phase I study evaluated the safety, tolerability, pharmacokinetics and preliminary tumor response of a nanoparticulate formulation of paclitaxel (Nanotax®) administered intraperitoneally for multiple tr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b7fd8abcc0658488d2a9e97da2730e1
https://doi.org/10.1007/s00280-015-2737-4
https://doi.org/10.1007/s00280-015-2737-4
Autor:
Christine B, Mackay, Kaitlyn R, Antonelli, Suanna S, Bruinooge, Jarron M, Saint Onge, Shellie D, Ellis
Publikováno v:
Cancer. 123(15)
The Affordable Care Act (ACA) includes a mandate requiring most private health insurers to cover routine patient care costs for cancer clinical trial participation; however, the impact of this provision on cancer centers' efforts to accrue patients t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::45a9fbeb4f8d4bc8a7c0e9c45f39d609
https://pubmed.ncbi.nlm.nih.gov/28334438
https://pubmed.ncbi.nlm.nih.gov/28334438
Publikováno v:
Respiratory investigation. 55(5)
Background In most Western nations, the medical oncologist plays a significant role in the administration of systemic therapy for lung cancer. In Japan however, treatment for lung cancer has historically been provided by pulmonologists and thoracic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d94f2965b1ccbf7f26b52cc544cebf5d
https://pubmed.ncbi.nlm.nih.gov/28942886
https://pubmed.ncbi.nlm.nih.gov/28942886
Publikováno v:
Journal of Clinical Oncology. 37:e18037-e18037
e18037 Background: Clinical trial enrollment at a group of community oncology sites dropped significantly surrounding acquisition by an academic medical center. While previous research used empirical data to identify enrollment barriers, this study u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2c51d7832413ca700af6f4e89f02eee0
https://doi.org/10.1200/jco.2019.37.15_suppl.e18037
https://doi.org/10.1200/jco.2019.37.15_suppl.e18037
Publikováno v:
International journal of clinical oncology. 22(2)
In the United States, medical oncologists play a central role in the management of systemic therapy for cancer patients. Medical oncology as a specialty is not as established in Japan and several other European nations according to recent surveys, an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1afa91fa9abb16d8e80d2955eb5b7d6d
https://pubmed.ncbi.nlm.nih.gov/27787627
https://pubmed.ncbi.nlm.nih.gov/27787627
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 2, Iss C, Pp 69-74 (2016)
Contemporary Clinical Trials Communications, Vol 2, Iss C, Pp 69-74 (2016)
Background Participation in cancer clinical trials has been shown to increase overall survival with minimal increase in cost, but enrollment in adult cancer clinical trials remains low. One factor limiting enrollment is lack of insurance coverage, bu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe544faa998dc56ccdb72e6fc0422c7f
https://pubmed.ncbi.nlm.nih.gov/29736447
https://pubmed.ncbi.nlm.nih.gov/29736447